Cargando…

In Vitro Antimicrobial Activities of Tigecycline, Eravacycline, Omadacycline, and Sarecycline against Rapidly Growing Mycobacteria

Infections caused by rapidly growing mycobacteria (RGM) have increased globally. Chemotherapy against these infections is challenging due to the minimal antimicrobial choices available. The main aim of this study was to evaluate the in vitro susceptibilities of four tetracyclines against different R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tingting, Du, Jian, Dong, Lingling, Wang, Fen, Zhao, Liping, Jia, Junnan, Wang, Congli, Cheng, Mengli, Yu, Xia, Huang, Hairong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927410/ https://www.ncbi.nlm.nih.gov/pubmed/36475850 http://dx.doi.org/10.1128/spectrum.03238-22

Ejemplares similares

Omadacycline, Eravacycline, and Tigecycline Express Anti-Mycobacterium abscessus Activity In Vitro
por: Li, Anqi, et al.
Publicado: (2023)

In Vitro Activity of the Novel Tetracyclines, Tigecycline, Eravacycline, and Omadacycline, Against Moraxella catarrhalis
por: Sun, Xiang, et al.
Publicado: (2021)

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolates
por: Zeng, Weiliang, et al.
Publicado: (2022)

1586. A Comparative Analysis of In Vitro Susceptibilities of Vancomycin-Resistant Enterococci Against Doxycycline, Minocycline, Tigecycline, Eravacycline and Omadacycline
por: Chua, Mary Francine P, et al.
Publicado: (2020)

AdeABC Efflux Pump Controlled by AdeRS Two Component System Conferring Resistance to Tigecycline, Omadacycline and Eravacycline in Clinical Carbapenem Resistant Acinetobacter nosocomialis
por: Lee, Yi-Tzu, et al.
Publicado: (2020)

In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China
por: Yu, Xia, et al.
Publicado: (2021)

Evaluating the Efficacy of Eravacycline and Omadacycline against Extensively Drug-Resistant Acinetobacter baumannii Patient Isolates
por: Deolankar, Manas S., et al.
Publicado: (2022)

Doubled Nontuberculous Mycobacteria Isolation as a Consequence of Changes in the Diagnosis Algorithm
por: Chen, Suting, et al.
Publicado: (2022)

Novel Tet(L) Efflux Pump Variants Conferring Resistance to Tigecycline and Eravacycline in Staphylococcus Spp.
por: Wang, Nannan, et al.
Publicado: (2021)

Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan
por: Hatakeyama, Shuji, et al.
Publicado: (2017)

Sarecycline: First Global Approval
por: Deeks, Emma D.
Publicado: (2019)

Correction to: Sarecycline: First Global Approval
por: Deeks, Emma D.
Publicado: (2019)

Sarecycline: A Review of Preclinical and Clinical Evidence
por: Moore, Angela Yen, et al.
Publicado: (2020)

Bloodstream infections with rapidly growing nontuberculous mycobacteria
por: Comba, Isin Yagmur, et al.
Publicado: (2021)

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects
por: Gotfried, Mark H., et al.
Publicado: (2017)

National evaluation of rapidly growing mycobacteria outbreaks in Brazil
por: Padoveze, MC, et al.
Publicado: (2011)

Drug Susceptibility Testing of 31 Antimicrobial Agents on Rapidly Growing Mycobacteria Isolates from China
por: Pang, Hui, et al.
Publicado: (2015)

New RAPMYCOI Sensititre(TM) Antimicrobial Susceptibility Test for Atypical Rapidly Growing Mycobacteria (RGM)
por: Borek, Anna, et al.
Publicado: (2022)

In vitro activities of omadacycline, eravacycline, cefiderocol, apramycin, and comparator antibiotics against Acinetobacter baumannii causing bloodstream infections in Greece, 2020–2021: a multicenter study
por: Galani, Irene, et al.
Publicado: (2023)

National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017–2020
por: Chien, Ying-Chun, et al.
Publicado: (2021)

Evaluation of INNO-LiPA mycobacteria v2 assay for identification of rapidly growing mycobacteria
por: García-Agudo, Lidia, et al.
Publicado: (2011)

Antimicrobial Resistance in Rapidly Growing Nontuberculous Mycobacteria among Domestic and Wild Animals Emphasizing the Zoonotic Potential
por: Reil, Irena, et al.
Publicado: (2023)

Antibacterial Mechanisms and Efficacy of Sarecycline in Animal Models of Infection and Inflammation
por: Bunick, Christopher G., et al.
Publicado: (2021)

In vitro activity of bedaquiline against rapidly growing nontuberculous mycobacteria
por: Aguilar-Ayala, Diana A., et al.
Publicado: (2017)

Omadacycline Enters the Ring: A New Antimicrobial Contender
por: Barber, Katie E., et al.
Publicado: (2018)

Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan
por: Kamada, Keisuke, et al.
Publicado: (2021)

Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria
por: Esteban, Jaime, et al.
Publicado: (2008)

Effect of ciprofloxacin in the ultrastructure and development of biofilms formed by rapidly growing mycobacteria
por: Muñoz-Egea, María-Carmen, et al.
Publicado: (2015)

In Vitro Activity of Eravacycline and Comparator Antimicrobials Against 143 Strains of Bacteroides Species.
por: Citron, Diane, et al.
Publicado: (2017)

Sarecycline interferes with tRNA accommodation and tethers mRNA to the 70S ribosome
por: Batool, Zahra, et al.
Publicado: (2020)

Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris
por: Moore, Angela Yen, et al.
Publicado: (2019)

Draft Genome Sequence of Mycobacterium wolinskyi, a Rapid-Growing Species of Nontuberculous Mycobacteria
por: de Man, Tom J. B., et al.
Publicado: (2016)

Rapidly Growing Mycobacteria Associated with Laparoscopic Gastric Banding, Australia, 2005–2011
por: Wright, Hugh L., et al.
Publicado: (2014)

Key Transitions in the Evolution of Rapid and Slow Growing Mycobacteria Identified by Comparative Genomics
por: Bachmann, Nathan L., et al.
Publicado: (2020)

Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents
por: Pang, Hui, et al.
Publicado: (2017)

Skin and Soft Tissue Infection due to Rapidly Growing Mycobacteria: Case Series and Literature Review
por: Yu, Jung Re, et al.
Publicado: (2013)

Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
por: Zhanel, George, et al.
Publicado: (2018)

Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode
por: Marini, Emanuela, et al.
Publicado: (2019)

1243. Eravacycline in Bacteremia: A Case Series
por: Andrade, Justin A, et al.
Publicado: (2021)

Omadacycline: a novel aminomethylcycline
por: Burgos, Rodrigo M, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h1lg4nk1pmv9asq2v11bd6lab0